Liu et al. revealed that in breast cancer, high mobility group box 1 (HMGB1) functions as an extracellular signaling molecule and is secreted by CAFs via the GPR30/PI3K/AKT signaling pathway. The gene discussed is HMGB1; the disease is breast carcinoma.